CG Oncology, Inc.

NasdaqGS:CGON Stock Report

Market Cap: US$2.3b

CG Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:CGON Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
29 Aug 24SellUS$8,000,023Hong Fang SongIndividual226,245US$35.36
29 Aug 24SellUS$15,000,066Unique Diamond Investments LimitedCompany424,210US$35.36
29 Jan 24BuyUS$38,000Corleen RocheIndividual2,000US$19.00
29 Jan 24BuyUS$24,985Vijay KasturiIndividual1,315US$19.00
29 Jan 24BuyUS$4,999,983Hong Fang SongIndividual263,157US$19.00
29 Jan 24BuyUS$15,200,000Decheng Capital LLCCompany800,000US$19.00

Insider Trading Volume

Insider Buying: CGON insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CGON?
Owner TypeNumber of SharesOwnership Percentage
Private Companies586,9820.868%
General Public1,597,9772.36%
Public Companies3,543,5335.24%
Individual Insiders4,488,4616.64%
VC/PE Firms13,811,29720.4%
Institutions43,601,42564.5%

Dilution of Shares: CGON only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 78.78% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.1%
Decheng Capital LLC
5,478,810US$186.0m0.37%39.93%
7.51%
The Vanguard Group, Inc.
5,081,352US$172.5m126%no data
6.89%
Longitude Capital Management Co., LLC
4,662,281US$158.3m0%26.95%
6.38%
Hong Fang Song
4,317,859US$146.6m-4.98%no data
5.43%
TCG Crossover Management, LLC
3,670,206US$124.6m0%10.1%
5.28%
BlackRock, Inc.
3,570,927US$121.2m80.7%no data
5.24%
Kissei Pharmaceutical Co., Ltd.
3,543,533US$120.3m0%no data
4.69%
Braidwell LP
3,170,875US$107.7m-4.19%4.56%
2.62%
Kynam Capital Management, LP
1,770,805US$60.1m3,180%4.49%
2.51%
State Street Global Advisors, Inc.
1,700,653US$57.7m73%no data
2.45%
Avidity Partners Management, L.P.
1,656,000US$56.2m27.8%3.04%
2.26%
Janus Henderson Group plc
1,526,534US$51.8m6.97%0.02%
2.07%
RA Capital Management, L.P.
1,397,433US$47.4m0%0.56%
1.99%
RTW Investments, LP
1,344,074US$45.6m0%0.6%
1.81%
Franklin Resources, Inc.
1,223,893US$41.6m8.3%0.01%
1.66%
AllianceBernstein L.P.
1,124,905US$38.2m11.4%0.01%
1.59%
Geode Capital Management, LLC
1,078,527US$36.6m96.2%no data
1.47%
BVF Partners L.P.
994,596US$33.8m-58.9%0.96%
1.44%
Cormorant Asset Management, LP
975,000US$33.1m0%1.53%
1.43%
Polar Capital Holdings Plc
967,055US$32.8m0%0.12%
1.36%
Ally Bridge Group
922,248US$31.3m-65.4%11.02%
1.26%
Deerfield Management Company, L.P. Series C
850,695US$28.9m96.2%0.47%
1.14%
Frazier Life Sciences Management, LP
770,000US$26.1m0%1.02%
1.1%
Point72 Asset Management, L.P.
746,063US$25.3m568%0.06%
1.08%
Perceptive Advisors LLC
733,695US$24.9m0%0.53%